Company
United StatesAlloSource, Chicago, IL – FDA Inspections
Inspection records and compliance data for AlloSource in Chicago, Illinois. 5 FDA inspections on record, last inspected August 30, 2022.
Company Profile
This profile covers AlloSource based in Chicago, Illinois, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected April 28, 2010. Last inspected August 30, 2022.
Most cited issue areas
- Contamination, mix ups, improper release1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 30, 2022 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1180198 |
| May 22, 2017 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1012394 |
| March 5, 2015 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 916763 |
| March 12, 2012 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 771277 |
| April 28, 2010 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 659873 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
AlloSource
FEI Number
3003657798
Address
311 W Superior St Ste 212, Chicago, Illinois 60654, United States
Country
United States
ID: 32725054-4001-4286-a064-38334040c623